iRhythm Technologies reported strong Q2 results with revenue up 20.1% to $224.2 million and earnings of $0.58 per share, beating expectations. Profitability improved with a gross margin of 72.8% and adjusted EBITDA of $43.3 million. Following this, Truist Financial raised the price target from $160 to $168, indicating a 35.35% upside. The company also raised its full-year revenue guidance and plans to acquire VitalConnect to expand its patient-monitoring product range.
Bitcoin has stabilized around $77,000 as the crypto market anticipates the Federal Reserve's interest rate decision this Wednesday, with a 90% chance of a 0.25% hike. After peaking at $81,200 in late August, Bitcoin retreated and consolidated in the ...
The Schwab U.S. Broad Market ETF (SCHB) currently holds about 2,380 U.S. stocks but has a high concentration risk, with 33.7% of its assets in the top 10 holdings and 36% in the technology sector. This concentration is increasingly hard to justify as...
Paxos' USDG stablecoin reached a remarkable $21.8 billion in trading volume on Uniswap during September, accounting for 98% of its decentralized exchange activity. This surge was driven by Uniswap's launch of the StablePair Hook, a dynamic fee system...
The Federal Reserve's first interest rate increase since 2023 is estimated to boost Interactive Brokers' annual revenue by about $81 million. This rate hike reflects the Fed's monetary policy shift and directly benefits brokerage firms like Interacti...
Russia's Moscow Exchange (MOEX) will launch perpetual futures contracts for XRP alongside Bitcoin, Ethereum, Solana, and TRON on September 22. These contracts, quoted in USD but settled in Russian rubles, allow qualified investors to gain price expos...
